NAIRO QUINTANA EXCLUDED FROM TOUR DE FRANCE: HAS TAKEN TRAMADOL

newsletter | 08/17/2022 | 15:11
by tuttobiciweb

This is announced by the International Cycling Union Colombian sprinter Nairo Alexandre Quintana Rojas was punished for violating the ban on the use of tramadol in competitions provided for by the UCI Medical Regulations with the aim of protecting the safety and health of runners in light of the side effects of this substance.

Analysis of two dried blood samples given by the rider on July 8 and 13 during the 2022 Tour de France revealed the presence of tramadol and its major metabolites.

According to the medical rules of the UCI, The rider has been disqualified from the 2022 Tour de France (where he finished sixth at 16’33” from Vingegaard) This decision can be appealed to the Court of Arbitration for Sport (CAS) within the next 10 days.

During the 2022 Tour de France, as part of the Tramadol program 120 dried blood samples were collected. Violations of the ban on the use of tramadol in competition are offenses under the UCI Medical Rules, but do not constitute a violation of anti-doping regulations. As this is the first offense, Nairo Alexander Quintana Rojas has not been suspended and can therefore participate in competitions. The UCI will not comment further on this matter.

tramadol; Since March 1, 2019, the UCI has banned the use of tramadol (opioid pain relievers) In competitions in all disciplines and categories in order to preserve the health and safety of runners in light of the side effects of this substance. Samples are collected by the International Testing Agency (ITA) using the Dried Blood Spot (DBS) reference method. Developed by the Swiss company DBS Systems, sampling kits are used to perform this minimally invasive test, which involves collecting a small amount of blood from the tip of a rider’s finger. Sample analysis is performed independently in the Laboratory of Pharmacy and Toxicology at the University of Geneva, using the peer-reviewed method to determine the presence or absence and quantity of tramadol and its major metabolites. The results are then submitted to the Center for Research and Competence in Anti-Doping Sciences at the University of Lausanne (RED) for a final independent review. The results are finally submitted to the UCI Medical Director, who administers the results in accordance with UCI Medical Rules.

UCI press release

Copyright and copy TBW